Skip to main content
. 2012 Sep;87(9):835–842. doi: 10.1016/j.mayocp.2012.04.013

TABLE 3.

MADR Assay Performance Compared With Cystoscopy/Biopsy for the Validation Populationa,b

Biopsy positive Biopsy/cystoscopy negative Total
Combined biomarkers intermediate/positive 51 (14.4) 302 (85.6) 353
Combined biomarkers negative 7 (1.8) 388 (98.2) 395
Total 58 (7.8) 690 (92.2) 748
a

MADR = multianalyte diagnostic readout.

b

Data are presented as No. (percentage).